Structural characterization of copper (II) binding to α-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease
RM Rasia, CW Bertoncini, D Marsh… - Proceedings of the …, 2005 - National Acad Sciences
The aggregation of α-synuclein (AS) is characteristic of Parkinson's disease and other
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
[PDF][PDF] Structural characterization of copper (II) binding to-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease
RM Rasia, CW Bertoncini, D Marsh, W Hoyer… - PNAS, 2005 - academia.edu
The aggregation of-synuclein (AS) is characteristic of Parkinson's disease and other
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
Structural Characterization of Copper (II) Binding to α-Synuclein: Insights into the Bioinorganic Chemistry of Parkinson's Disease
RM Rasia, CW Bertoncini, D Marsh, W Hoyer… - Proceedings of the …, 2005 - JSTOR
The aggregation of α-synuclein (AS) is characteristic of Parkinson's disease and other
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
[HTML][HTML] Structural characterization of copper (II) binding to α-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease
RM Rasia, CW Bertoncini, D Marsh… - Proceedings of the …, 2005 - ncbi.nlm.nih.gov
The aggregation of α-synuclein (AS) is characteristic of Parkinson's disease and other
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
Structural characterization of copper (II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease
RM Rasia, CW Bertoncini, D Marsh, W Hoyer… - 2005 - publications.goettingen-research …
The aggregation of alpha-synuclein (AS) is characteristic of Parkinson's disease and other
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
[PDF][PDF] Structural characterization of copper (II) binding to-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease
RM Rasia, CW Bertoncini, D Marsh, W Hoyer… - PNAS, 2005 - researchgate.net
The aggregation of-synuclein (AS) is characteristic of Parkinson's disease and other
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
Structural characterization of copper (II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease
RM Rasia, CW Bertoncini, D Marsh… - Proceedings of the …, 2005 - pubmed.ncbi.nlm.nih.gov
The aggregation of alpha-synuclein (AS) is characteristic of Parkinson's disease and other
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
Structural characterization of copper (II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease.
RM Rasia, CW Bertoncini, D Marsh… - Proceedings of the …, 2005 - europepmc.org
The aggregation of α-synuclein (AS) is characteristic of Parkinson's disease and other
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
Structural characterization of copper (II) binding to α-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease
RM Rasia, CW Bertoncini, D Marsh, W Hoyer… - Proceedings of the …, 2005 - cir.nii.ac.jp
抄録< jats: p> The aggregation of α-synuclein (AS) is characteristic of Parkinson's disease
and other neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are …
and other neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are …
Structural characterization of copper (II) binding to α-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease
RM Rasia, CW Bertoncini, D Marsh… - Proceedings of the …, 2005 - ui.adsabs.harvard.edu
The aggregation of α-synuclein (AS) is characteristic of Parkinson's disease and other
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …
neurodegenerative synucleinopathies. We demonstrate here that Cu (II) ions are effective in …